HCV-RELATED MIXED CRYOGLOBULINEMIA AND BAFF PROMOTER POLYMORPHISM

被引:0
|
作者
Giannini, C. [1 ]
Gragnani, L. [1 ]
Piluso, A. [1 ]
Caini, P. [1 ]
Petrarca, A. [1 ]
Monti, M. [1 ]
Laffi, G. [1 ]
Zignego, A. L. [1 ]
机构
[1] Univ Florence, Dept Internal Med, MASVE Ctr, Florence, Italy
关键词
D O I
10.1016/S0168-8278(09)60880-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
878
引用
收藏
页码:S319 / S320
页数:2
相关论文
共 50 条
  • [41] Necrotizing acute pancreatitis following therapeutic plasmapheresis in HCV-related cryoglobulinemia
    Desideri, F.
    Van Vlierberghe, H.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2011, 74 (02) : 355 - 358
  • [42] HCV-related cryoglobulinemia mimicking systemic autoimmune disease (The Hispamec Study)
    Garcia-Carrasco, M
    Medina, F
    Jara, LJ
    Rosas, J
    Anaya, JM
    Font, J
    Ramos-Casals, M
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 446 - 446
  • [43] EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma
    Wang, Jia
    Zhong, Yanlin
    Meng, Guixia
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (11) : 2053 - 2064
  • [44] Cryoglobulinemia does not influence the success of interferon therapy for chronic HCV-related hepatitis
    Pellicano, R
    Palmas, F
    Arena, V
    Marietti, G
    Cossotto, D
    Pugliese, G
    Fenoglio, L
    Rizzetto, M
    Ponzetto, A
    GASTROENTEROLOGY, 1997, 112 (04) : A1356 - A1356
  • [45] Immunoadsorption Apheresis and Immunosuppressive Drug Therapy in the Treatment of Complicated HCV-Related Cryoglobulinemia
    Stefanutti, Claudia
    Vivenzio, Antonio
    Di Giacomo, Serafina
    Labbadia, Giancarlo
    Mazza, Fabio
    D'Alessandri, Giovanna
    Ferraro, Pietro M.
    Masala, Cesare
    JOURNAL OF CLINICAL APHERESIS, 2009, 24 (06) : 241 - 246
  • [46] EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma
    Jia Wang
    Yanlin Zhong
    Guixia Meng
    International Journal of Clinical Oncology, 2021, 26 : 2053 - 2064
  • [47] The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals
    Tonutti, Antonio
    Polverini, Davide
    De Nicola, Stella
    Ceribelli, Angela
    Soleri, Matteo
    De Santis, Maria
    Aghemo, Alessio
    Selmi, Carlo
    Pugliese, Nicola
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2025, 23 (01) : 19 - 30
  • [48] Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia: results of a large, prospective study
    Piluso, A.
    Giannini, C.
    Fognani, E.
    Gragnani, L.
    Caini, P.
    Monti, M.
    Petrarca, A.
    Ranieri, J.
    Urraro, T.
    Triboli, E.
    Laffi, G.
    Zignego, A. L.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (04) : e107 - e114
  • [49] ETIOLOGICAL THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME: THE ROLE OF IL28B GENOTYPE AS PREDICTOR OF RESPONSE
    Urraro, T.
    Piluso, A.
    Giannini, C.
    Fognani, E.
    Gragnani, L.
    Caini, P.
    Monti, M.
    Triboli, E.
    Pellegrini, E.
    Petrarca, A.
    Ranieri, J.
    Laffi, G.
    Zignego, A. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 117 - 118
  • [50] Is T(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia?
    Giannelli, F
    Ferri, C
    Marrocchi, MF
    La Civita, L
    Longombardo, G
    Gianniní, C
    Pulití, A
    Giallombardo, AL
    Montí, M
    Gentilini, P
    Zignego, AL
    JOURNAL OF HEPATOLOGY, 2000, 32 : 36 - 36